Insulet Corporation’s (PODD) Wearable Pod Tech Finds New Frontier

Insulet Corporation’s (PODD) Wearable Pod Tech Finds New Frontier

Thu, August 13, 2026 at 4:04 PM GMT+3 3 min read

• PODD +0.05%

Alpha Wealth Funds, LLC, an investment management company, released its Q2 2026 letter for the "Insiders Fund". A copy of the letter is available to download here. The Fund lost 1.45% in June, while it was up 8.43% for the 2nd quarter and 0.75% YTD. This compares to the S&P 500's -0.95%, 15.2%, and 9.98% returns, respectively, over the same period. The fund underperformed while the S&P 500 and Nasdaq-100 posted their best quarter in six years. A significant factor in this decline is a ~30% concentration in Alphabet stock, which shifted from a cash-generating asset to a capital-intensive posture following a major stock offering to fund data centers. The performance of the fund was further hampered by losses in AI semiconductor stocks like AMD and Intel, which were sold prematurely. The letter concluded with a commitment to risk management while acknowledging the possibility of mistakes in investment strategy. In addition, please check the fund's top five holdings to know its best picks in 2026.

In its Q2 2026 investor letter, Insiders Fund highlighted Insulet Corporation (NASDAQ:PODD). Insulet Corporation (NASDAQ:PODD) is an American medical device company known for its Omnipod platform, an insulin delivery system for people with insulin-dependent diabetes. On August 12, 2026, Insulet Corporation (NASDAQ:PODD) closed at $161.28 per share. The one-month return of Insulet Corporation (NASDAQ:PODD) was -11.78%, and its shares lost 54.06% over the past 52 weeks. Insulet Corporation (NASDAQ:PODD) has a market capitalization of $11.17 billion.

Insiders Fund stated the following regarding Insulet Corporation (NASDAQ:PODD) in its Q2 2026 investor letter:

"Business: Insulet Corporation (NASDAQ:PODD) is a leader in medical technology, primarily known for its Omnipod Insulin Management System. Unlike traditional insulin pumps that require plastic tubing, the Omnipod is a wearable, waterproof "pod" that delivers insulin continuously. Insider Buying/Selling: Ashley McEvoy (President & CEO): Purchased 4,300 shares around February 20–25, 2026, at an average price of $239.35 per share, representing an investment of just over $1 million. ● Michael R. Minogue (Independent Director): Purchased 2,030 shares on February 26, 2026, at an average price of $246.23 per share, totaling approximately $499,800. Elizabeth Weatherman (Independent Chair): Most recently, in early June 2026, she purchased approximately $497,000 worth of stock at a lower price point of $144 per share, which boosted her total holdings by 66%.

Recent News: Insulet's (PODD) share price is currently caught in a tug-of-war between strong fundamental financial growth and escalating manufacturing and legal headwinds. Late May Correction: On May 26, 2026, Insulet had to initiate another voluntary medical device correction for specific lots of Omnipod 5, Dash, and Eros pods due to a cannula (tubing) tear that could lead to dangerous insulin under-delivery. This sent the stock price tumbling over 5% down to ~$146..." (Click here to read the full text)

Insulet Corporation (NASDAQ:PODD) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 55 hedge fund portfolios held Insulet Corporation (NASDAQ:PODD) at the end of the first quarter, compared to 60 in the previous quarter. While we acknowledge the potential of Insulet Corporation (NASDAQ:PODD) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on thebest short-term AI stock.

In another article, we covered Insulet Corporation (NASDAQ:PODD) and shared ClearBridge SMID Cap Growth Strategy's insight on the company. In addition, please check out our hedge fund investor letters Q2 2026 page for more investor letters from hedge funds and other leading investors.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. This article is originally published at Insider Monkey.